Afraid of needles? China offers inhalable COVID-19 vaccine
13:05 JST, November 8, 2022
BEIJING (AP) — The Chinese city of Shanghai started administering an inhalable COVID-19 vaccine on Oct. 26 in what appears to be a world first.
The vaccine, a mist that is sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated people, according to an announcement on an official city social media account.
Scientists hope that such “needle-free” vaccines will make vaccination more accessible in countries with fragile health systems because they are easier to administer. They also may persuade people who don’t like getting a shot in the arm to get inoculated.
China wants more people to get booster shots before it relaxes strict pandemic restrictions that are holding back the economy and are increasingly out of sync with the rest of the world. As of mid-October, 90% of Chinese were fully vaccinated and 57% had received a booster shot.
A video posted by an online Chinese state media outlet showed people at a community health center sticking the short nozzle of a translucent white cup into their mouths. The accompanying text said that after slowly inhaling, people hold their breath for five seconds, with the entire procedure completed in 20 seconds. “It was like drinking a cup of milk tea,” one Shanghai resident said in the video. “When I breathed it in, it tasted a bit sweet.”
The effectiveness of non-needle vaccines has not been fully explored. Chinese regulators approved the inhalable one in September, but only as a booster shot after studies showed it triggered an immune system response in people who had previously received two shots of a different Chinese vaccine.
A vaccine taken as mist could fend off the virus before it reaches the rest of the respiratory system, though that would depend in part on the size of the droplets, one expert said.
Larger droplets would train defenses in parts of the mouth and throat, while smaller ones would travel further into the body, said Dr. Vineeta Bal, an immunologist in India.
The inhalable vaccine was developed by Chinese biopharmaceutical company CanSino Biologics Inc. as an aerosol version of the company’s one-shot adenovirus vaccine, which uses a relatively harmless cold virus.
The traditional one-shot vaccine has been approved for use in more than 10 markets including China, Hungary, Pakistan, Malaysia, Argentina and Mexico.
"World" POPULAR ARTICLE
-
UNRWA Director Describes Catastrophic Destruction in Gaza; Says Relief Trucks Robbed, ‘People’s Hearts Destroyed’
-
Paparo Stresses Ties with Allies at U.S. Indo-Pacific Change of Command Ceremony; U.S. Defense Secretary Emphasizes Strengthening Deterrence Against China
-
Parents Seek Truth of Daughter’s Death in Italy; New Investigation Launched 3 Years On
-
Brazilian President Lula Aims to Work with Japan on UNSC Reform, Condemns Israeli Attacks on Gaza as ‘Genocide’
-
North Korea Plants Land Mines on Roads to South; Kim’s Move Seen As Ratcheting Up Tension
JN ACCESS RANKING
- Weakening Yen Adds Complexity to BOJ’s Rate Hike Decisions; Rising Commodity Prices may Impact ‘Virtuous Cycle’ Efforts
- Japanese Seafood Exports to China Sink 57% in FY23; U.S. Becomes Largest Seafood Export Destination
- 70% of Japan Companies to Raise Pay Scales in FY 2024
- 48.6% of Global Patent Applications Related to All-Solid-State Batteries Came from Japanese Firms; Panasonic Tops List
- U.S. 7th Fleet officer Arrested on Suspicion of Stealing Sushi, Sashimi, Chicken at Kanagawa Shopping Mall; Suspect Caught Mid-Meal